Smart Equity Invest

← Results dashboard

Q2 FY27 · NSE: WEBELSOLAR

Websol Energy System

Results filed 5 November 2026 · Market cap ₹3,082 crore · PE 8.9

GrowthGuidance maintainedTranscript read

Revenue
+114.6%
on a year ago
EBITDA
+77.3%
on a year ago
Profit to shareholders
+73.2%
on a year ago
EBITDA margin
35.5%
+1.8 pts on last quarter

Websol delivered Q2 FY27 revenue of Rs 361 crore (up 114.6% YoY) and net profit of Rs 80 crore, underpinned by 91% cell capacity utilization and 255 MW output. The company fully repaid its Rs 110 crore IREDA term loan to become net debt-free and secured 54.2 acres at Falta for a phased 4 GW greenfield cell expansion. Management guided for full-year FY27 EBITDA margins to moderate toward 30% while progressing on its brownfield 750 MW TOPCon upgrade targeted for Q4 FY27.

Websol Energy System Limited, Q2 FY27₹ crore, consolidated
Q2 FY27Q1 FY27vs previous quarterQ2 FY26vs a year ago
Revenue361373−3.1%168+114.6%
Operating profit (EBIT)106104+2.2%61.3+73.0%
Operating margin29.4%27.8%+153 bps36.4%−707 bps
Other income4.314.38−1.6%3.28+31.4%
Exceptional items00–0–
Profit before exceptional items and tax107104+2.5%59.85+78.1%
Profit to shareholders80.2177.79+3.1%46.32+73.2%
Earnings per share (₹)1.851.79+3.4%10.97n.m.

Source: Websol Energy System Limited’s filing to NSE, 4 November 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss, or, for earnings per share, because the number of shares changed.

What stood out

  • Prepayment of entire IREDA debt, turning net debt-free with net cash of Rs 165 crore and reducing promoter pledge from ~80% to 16%
    SourceEntire Rs 110 Cr IREDA term loan prepaid on 4th August 2026 from internal accruals; pledge on promoter shares released... Net Debt/(Net Cash) at (165) Cr (Presentation, Page 10)
  • Cell line operating at high capacity utilization of 91% producing 255 MW in Q2 FY27
    SourceOur solar cell line operated at 91% utilization in Quarter 2. We produced a little over 255 megawatt of cells (Transcript, Page 3 / MD Sohan Lal Agarwal)
  • Significant gross and EBITDA margin compression YoY despite top-line doubling
    SourceEBITDA margin stood at 35.5% in Q2FY27 vs 43.0% in Q2FY26 (down 748 bps YoY), while Cost of Material Consumed jumped 201.5% YoY to Rs 190 crore (Presentation, Pages 7 and 29)

Guidance

MetricGuidancePeriod
EBITDA Margin
SourceWe expect, EBITDA margin to stabilize in the range of 30% in this financial year. But considering the new capex is coming on, we do believe, some moderation will be there in the EBITDA margins (Transcript, Page 11 / CFO Amrit Daga)
Expected to stabilize around ~30% for FY27 with some moderation as capex comes onFY27
Cell Capacity
SourceSo by end of this financial year, we expect to be a cell capacity of 1.35 gigawatts, which includes 600 megawatt Mono-PERC and 750 megawatt TOPCon (Transcript, Page 8 / Sanjana Khaitan)
1.35 GW by end of FY27 (600 MW Mono PERC + 750 MW TOPCon)Q4 FY27
Phase 1 Greenfield Commercial Operation Date (COD)
Sourcestart trial runs by the third quarter of the next financial year... December '27 rather. So we will start our first 2 gigawatt TOPCon integrated facility (Transcript, Pages 6, 13)
Trial runs and COD targeted by Q3 FY28 (December 2027)Q3 FY28

Tailwinds

  • Operational stability with 91% cell utilization and 255 MW production, up from 116 MW in Q2 FY26
    SourceCell production for the quarter was 255 MW during Q2FY27, with capacity utilization of 91% (Presentation, Pages 2, 22)
  • Solid order book of Rs 1,280 crore providing near-term execution visibility
    SourceThe outstanding order book stood at Rs 1,280 crore as of 30 September 2026 (Presentation, Pages 2, 23)
  • Prepayment of high-cost IREDA debt resulting in debt-free status and lower finance costs
    SourceFinance costs declined 20.1% YoY to Rs 4 crore in Q2 FY27 post repayment of Rs 110 crore IREDA term loan on 4th August 2026 (Presentation, Pages 10, 29)
  • Strong operating cash flow generation of Rs 212 crore in H1 FY27
    SourceNet Cash from Operating Activities stood at Rs 212 crore in H1 FY27 compared to Rs 132 crore in H1 FY26 (Presentation, Page 31)

Headwinds

  • Sharp YoY decline in EBITDA margin due to surging raw material costs
    SourceEBITDA margin contracted 748 bps YoY from 43.0% to 35.5% as Cost of Material Consumed jumped 201.5% YoY to Rs 190 crore (Presentation, Page 29)
  • Sequential moderation in revenue from operations
    SourceRevenue from operations declined 3.1% QoQ to Rs 361 crore from Rs 373 crore in Q1 FY27 (Presentation, Page 29)
  • Module line capacity utilization remains subdued at 68%
    SourceModule production was 88 MW during Q2FY27, with capacity utilization of 68%, down from 81% in Q1 FY27 (Presentation, Pages 2, 22)

New businesses and products

capacity expansion · Land allocated (54.2 acres), land development underway, civil works to commence around January 2027

4 GW Greenfield Integrated TOPCon Cell Facility at Falta, West Bengal (Phase 1: 2 GW)

Expected benefit
Expand cell capacity to capture ALMM List-II demand and achieve economies of scale
Risks
Dependence on execution timelines and debt financing closure; technology risk
Timeline
Phase 1 trial runs expected by Q3 FY28 (around December 2027)
Investment
Estimated project cost of Rs 1,350 crore for Phase 1 (70% debt, 30% internal accruals/equity)
SourceWe have been allocated 54.2 acres of land for this 4-gigawatt integrated project... estimating a project cost of INR 1,350 crores for the first phase of 2 gigawatts... start trial runs by the third quarter of the next financial year (Transcript, Pages 6, 10, 16)

capacity expansion · Equipment ordered and shipped, civil works progressing, advances paid

Brownfield TOPCon Upgrade at Existing Falta Plant

Expected benefit
Increases cell capacity from 600 MW to 750 MW (total cell capacity reaches 1.35 GW) and raises efficiency from 23.35% to ~25%
Risks
Equipment delivery and integration risk during line conversion
Timeline
Trial runs and validation by Q4 FY27 (March 2027)
Investment
Rs 270 crore funded entirely via internal accruals
SourceOur conversion of an existing MonoPERC line to TOPCon is underway... moving from a 600 megawatt line to a planned 750 megawatt of TOPCon line... targeted towards the end of this financial year (Transcript, Page 4; Presentation, Page 26)

new business · Board approval received; subscription to 40% of Bright Earth Cell Private Limited approved for energy trading; CEO appointed for Websol Renewables

Entry into Forward-Integrated Verticals (EPC, Solar IPP, Solar Parks, Energy Trading)

Expected benefit
Captive and capital-light forward integration serving as a channel for internal cell and module sales
Risks
Execution in unproven downstream services verticals
Timeline
Early stage; operations in Websol Renewables starting alongside 2 GW TOPCon line in Q3 FY28
Investment
Capital light SPVs; financial outlays not yet disclosed
SourceThe Board has approved pursuing opportunities in EPC, solar independent power production, solar parks, and energy trading... approved the proposed subscription to 40% of Bright Earth Cell Private Limited (Transcript, Pages 5, 7)

new business · In evaluation stage; in technical discussions with providers (partnership with Linton Crystal)

Ingot and Wafer Facility (Backward Integration)

Expected benefit
Compliance with ALMM List-III; reduces reliance on imported wafers and improves margins
Risks
High capex and regulatory delays in ALMM List-III implementation
Timeline
Working towards June 2028 mandate, pending regulatory deadline clarity
Investment
Still evaluating; to be confirmed by Q3 FY27
SourcePartnership with Linton Crystal for equipment and technology support... we are still evaluating, exactly how much capex will be required (Presentation, Page 24; Transcript, Page 11)

Things to check

  • Revenue up over 60%: check for an acquisition or a weak year-ago quarter
  • Significant capex commitments planned (Rs 1,350 crore Phase 1 plus upcoming wafer capex) compared to current net worth of Rs 777 crore, involving planned re-leveraging up to 70% debt
    SourceYes, we are targeting as of now is, around 30% equity, 70% debt... But we want to take a 70, 30 sanction from a perspective that we see further capex coming our way (Transcript, Pages 10, 16)
  • Scope creep into non-core capital-intensive downstream activities (EPC, IPP, Solar Parks, Energy Trading)
    SourceThe Board has approved pursuing opportunities in EPC, solar independent power production, solar parks, and energy trading. It has also approved the proposed subscription to 40% of Bright Earth Cell Private Limited (Transcript, Page 5)

How the call went

The call provided operational clarity regarding the 600 MW to 750 MW TOPCon upgrade and the Rs 1,350 crore Phase 1 Falta facility, but management avoided providing forward-looking metrics for FY28/29 margins and downstream EPC/trading initiatives.

Specific or vague
Reasonable detail provided on existing plant capacity utilization, TOPCon upgrade costs (Rs 270 crore), Phase 1 Falta capex (Rs 1,350 crore), and debt mix, but vague on wafer capex and future margin trajectory beyond FY27.
Candour
Management was open about expecting EBITDA margin compression down to ~30% for the full year and acknowledged that cell capacity additions across India have lagged expectations.
The hard questions
Analysts probed deeply into capex funding, debt-equity mix shifts, reliance on Chinese technology equipment amid geopolitical restrictions, and revenue viability of new EPC/IPP ventures.

What analysts pressed on

  • Funding and leverage structure for the Rs 1,350 crore greenfield expansion and subsequent wafer plant
  • Impact of Chinese export restrictions on TOPCon manufacturing equipment and technology access
  • Sustainability of elevated EBITDA margins in FY28 and FY29 given rising competition and industry expansions
  • Capital allocation and risk profile of entering forward-integrated downstream businesses like EPC, solar IPP, and energy trading

Answers that sidestepped

  • Refusal to provide any margin outlook for FY28/FY29 ('it's very difficult to comment on what will be the margin on FY28, FY29 because there are, many external forces')
  • Deflection on expected revenue accruals or scale from EPC and IPP businesses ('premature to be commenting on projected revenues')

Numbers against the story

Management emphasized strong profit growth (PAT up 73% YoY to Rs 80 crore) and a debt-free balance sheet, but the reported figures highlight a 748 bps YoY EBITDA margin contraction to 35.5% as raw material expenses more than tripled (+201.5% YoY). Furthermore, while management guided for strong growth, sequential revenue contracted by 3.1% QoQ, and management guided full-year FY27 EBITDA margins further down to around 30%.

Sources

Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.